We believe that innovation and excellence in research are essential to produce premium products that match the current and future requirements in animal health. To achieve these ambitious goals, Vaxxinova invests strongly in R&D.


Vaxxinova is a young and international company. Our Headquarters are based in Nijmegen, the Netherlands. We have operations in 4 more countries: IZO (Italy), Vaxxinova GmbH in Germany, Vaxxinova Japan and Vaxxinova Norway.


Vaxxinova is part of the family-owned EW Group (EWG), a German based company specialized in animal genetics, nutrition and animal health. EWG is highly committed to R&D, operates in more than 50 countries and records consistent international growth.


Transistorweg 5 (Building M)

6534 AT Nijmegen

The Netherlands

+31 24 204 8600



More companies in this area

DFE Pharma

DFE Pharma develops, produces and supplies excipients for use in oral solid dose and dry powder inhalation,


TropIQ Health Sciences offers laboratory screening services for the discovery and development of drugs against malaria.

Protinhi Therapeutics

Protinhi Therapeutics is an early stage biotech company, developing novel drugs against diseases with a high unmet medical need using proprietary technology and compounds that target diseases via Protease Inhibition. The focus of Protinhi is on upcoming viral threats and particularly on Dengue and Zika.

Okklo Life Sciences

Okklo Life Sciences is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies, with a focus on neglected and orphan diseases.


Epigenetics is an exciting area of molecular biology that identifies key changes in gene activity that do not involve changes to the underlying genetic code.


Avivia is an independent specialized pharmaceutical development company engaged in drug repositioning, repurposing and reformulation.

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!